Augmented Sensory in Cancer-Related Neuropathic Patients"

Isra University, Jordan

Status

Completed

Conditions

Physical Therapy

Treatments

Combination Product: Gradual Intermittent pneumatic compression therapy (IPC),Balance excercises.PNF technique

Combination Product: selected physical therapy program as arm excercises

Study type

Interventional

Funder types

Other

Identifiers

NCT07027215

Augmented Sensory Feedback

Details and patient eligibility

About

this research studied the effect of augmented sensory feedback program on motor control and risk of falling in patient with CIPN.

Full description

Design: A randomized control trial was conducted to investigate the impact of augmented sensory feedback paradigm on motor control and risk of falling in patient with Chemotherapy-induced peripheral neuropathy. Data were collected pre and post treatment from out-patient clinic of the Faculty of Medicine and Faculty of Physical Therapy South Valley University, between January 2023and March 2024. The study was approved by the ethical committee of the Faculty of Physical Therapy, South Vally University, Egypt. The study protocol was explained in detail to every patient and signed written consent was obtained before participation.

Participants: forty female patients with CIPN were recruited from out-patient clinic of the Faculty of Medicine and Faculty of Physical Therapy South Valley University, between January 2023and March 2024.

Enrollment

40 patients

Sex

Female

Ages

35 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Forty female with age from 35-60 years
clinically diagnosed with CIPN after recovery from stage I or II breast cancer
The strength at the toes, ankles, knees, and hips, as determined by manual muscle tests, of at least 3/5.
The patients can walk independently with or without any assistive devices.

Exclusion criteria

Patients with a history of hereditary peripheral neuropathy
Diseases that may contribute to peripheral nerve damage, such as diabetes or renal insufficiency, alcohol abuse, HIV, and vasculitis.
Patient who had central or peripheral neurologic disease, brain or spinal cord metastases
Orthopedic problems influencing gait, or foot ulcer at the moment of intake.
Patients with vestibular or neurological problems influencing gait parameters
Subjects who had participated in regular exercise, as defined as 150 min of light-to-moderate intensity exercise per week over the past year, were excluded from this trial.